Under new plans to reduce the European Union’s overall spending, science funding did relatively well, but research leaders want more—and they may well get it.
Daily News Roundup
Under new plans to reduce the European Union’s overall spending, science funding did relatively well, but research leaders want more—and they may well get it.
One of the most advanced tuberculosis vaccines has failed to protect infants from getting the disease in a clinical trial, but it may be effective in adults.
A new study disputes findings of a 2011 analysis suggesting that black researchers are funded less than their equally qualified white peers.
A company offering experimental stem-cell treatments will carry out its procedures in Mexico after the FDA warned that it would need approval to operate in the U.S.
A drug applied to the ears of deaf mice has prompted the regrowth of noise-damaged hair cells and resulted in slight improvements in the animals’ hearing.
Elwood Jensen, whose research inspired new treatments for breast cancer, has passed away at age 92.
The Cancer Prevention and Research Institute of Texas has agreed to stop awarding new grants until it addresses concerns about the integrity of is review process.
After undergoing untested cosmetic surgery that uses stem cells to rejuvenate skin, a woman grew bone fragments in the flesh around one of her eyes.
The Cancer Prevention and Research Institute of Texas is under investigation following further concerns about the legitimacy of its grant review process.
Three patents on transgenic apes in the European Union will be challenged by animal rights activists.